Peroxisomal-deficient skin fibroblasts from patients with Zellweger's syndrome or infantile Refsum's disease produced fewer prostaglandins than normal skin fibroblasts. Radioimmunoassay indicated a 45-55% decrease in prostaglandin E2 (PGE2) production when Zellweger's fibroblasts were incubated with arachidonic acid. This deficiency was not overcome by pretreatment of the Zellweger's fibroblasts with media containing arachidonic acid, and it was not due to channeling of arachidonic acid into other eicosanoid products. Modifications in the peroxide tone of the Zellweger's fibroblasts by addition of H202 or catalase failed to increase PGE2 production. Using Northern analysis, we were unable to detect an mRNA transcript for PGH synthase in unstimulated Zellweger fibroblasts but identified a 4.2-kb mRNA transcript after treatment with phorbol myristate acetate (PMA). Treatment for 6 h with 10 nM PMA raised PGE2 production in normal and Zellweger fibroblasts to equivalent levels. These increases were prevented by addition of H-7, staurosporine, cycloheximide, or actinomycin D. Our findings suggest that the reduced PGE2 production in peroxisomal deficient fibroblasts is due to a decrease in PGH synthase mRNA. The reduction in PGH synthase can be overcome by treatment of the cells with agents which enhance gene expression. (J. Clin. Invest. 1993. 91:169-178.) Key words: phorbol ester* prostaglandins * protein kinase * Zellweger
Introduction
Peroxisomes are single membrane organelles 0.2-1.0 ,um in diameter that are ubiquitous in eukaryotic cells ( 1) . These organelles carry out a number of important biological functions. They contain catalase and thereby compartmentalize the detoxification of intracellular H202 (2), fl-oxidize long chain and very long chain fatty acids (3), synthesize the alkyl ether bond of plasmalogens (4) , produce bile acids (5) , catabolize phytanic acid (6) and pipecolic acid (7) , and are responsible for the chain-shortening ofhydroxyeicosatetraenoic acids (8) . The prototypical peroxisomal deficiency in humans has been desig-nated the Zellweger or cerebrohepatorenal syndrome ( 1 ) . This autosomal recessive disorder is characterized biochemically by the accumulation of phytanic acid and very long chain fatty acids, diminished plasmalogen synthesis, and decreased bile acid synthesis (9) . Clinically, the syndrome is associated with failure to thrive, severe hypotonia, epileptic seizures, psychomotor retardation, hepatic and renal cortical cysts, and premature death in the first 6-12 mo of life (1) . Liver and kidney tissue from infants with this syndrome have no demonstrable peroxisomes ( 10) . Other human peroxisomal deficiencies have been described, including infantile Refsum's disease. This disease, although not identical to Zellweger's syndrome, shares many of the same biochemical and clinical features (1) .
Prostaglandins (PGs) are important mediators ofa number of critical functions in mammalian cells and tissues ( 1 1). The control of PG formation depends on the availability of arachidonic acid and the activity of PGH synthase, a membranebound heme protein that has two activities, a cyclooxygenase component and a peroxidase component ( 12) . PGH synthase converts the arachidonic acid into an endoperoxide intermediate, PGH2 . Very little free arachidonic acid is found in cells; it is contained primarily in cellular phosphoglycerides and is released through the action of calcium-dependent phospholipases ( 13) .
None of the biochemical defects in peroxisomal-deficient cells described to date suggests that PG formation is abnormal. We have observed, however, that agonist stimulated PG formation in peroxisomal-deficient skin fibroblasts is markedly reduced. The reduction in PGE2 formation is not due to lack of substrate; it appears to be due to a reduced quantity of PGH synthase protein and mRNA transcription in the peroxisomaldeficient cells. Treatment of peroxisomal deficient cells with PMA restores PGH synthase enzyme activity, apparently through a pathway involving gene transcription and translation mediated by protein kinase C.
fibroblasts were studied between passages 3 and 7, infantile Refusum's disease fibroblasts between passages 9 and I 1, and normal human skin fibroblasts between passages 18 and 24. Cultures were maintained in a temperature-and humidity-controlled incubator (CO2 Incubator 3028; Forma Scientific, Inc., Marietta, OH) at 370C with 95% air-5% CO2 as the gas phase. The DNA content of the cells was measured fluorometrically ( 14) .
Incubation and lipid analysis. After removal of the maintenance medium, the cells were washed twice with Dulbecco's PBS (DPBS)' containing 0.1 MuM BSA and incubated for 20 min at 370C in 1 ml of modified Eagle's MEM containing 7.5 MM [I-'4C]arachidonic acid and 0.1 MuM BSA. After incubation, the medium was removed and placed in a siliconized glass tube, and the pH was adjusted to 3.5 by addition of 10 MAl of2.4 N HCl. Lipids were extracted three times with 2 vols of HPLC-grade ethyl acetate. The ethyl acetate extracts were pooled, evaporated to dryness under a stream of nitrogen, and resuspended in 500 Ml of acetonitrile. The radioactive lipids were analyzed by, reverse-phase HPLC (8) .
Fatty acid methyl esters were prepared from the cell lipids extracted into chloroform/methanol solution (2:1, vol/vol) by incubation with boron trifluoride in methanol and acetonitrile for 30 min at 90'C. After extraction of the methyl esters with water and heptane, the samples were dried under N2 and resuspended in 25 Ml of carbon disulfide, and 1 ml was injected into a model 5890 gas chromatograph (HewlettPackard Co., Palo Alto, CA) for separation of fatty acid methyl esters. Fatty acids were identified by comparison of the relative retention times with fatty acid methyl ester standards.
PGformation. To determine PGE2 production after agonist stimulation, the maintenance medium was removed, and the cells were washed twice with DPBS containing 0.1 MM BSA and then incubated for 20 min in 0.5 ml DPBS containing 0.1 MM BSA and 7.5,uM arachidonic acid. The buffer solution was removed and analyzed for PGE2 production by RIA ( 15) . Measurement of PGE2 production by normal, infantile Refsum's disease, and Zellweger human skin fibroblasts was accomplished by mixing 100 Ml ofeither standards or samples with 50 M1 of anti-PGE2 antibody (Anti-PGE2 antibody, Advanced Magnetics Corp., Cambridge, MA). The mixture was incubated at 25°C for 30 min, 50 Mul of [3H]PGE2 [10-15 X I03 dpm] was added, and the incubation was continued for 16 h at 4°C. Dextran-coated charcoal (400 M1) was added and after mixing and centrifugation at 3,000 g for 15 min, the radioactivity in 400 Ml of the supernatant fluid was measured in a liquid scintillation spectrometer. Assay detection limits were 5 pmol of PGE2, and 50% inhibition was obtained with 15 pmol/ml PGE2. The assay has negligibly small amounts of cross reactivity with prostaglandins other than PGE2-To determine if soluble factor(s) produced by either the normal or Zellweger fibroblasts could affect PGE2 production, conditioned medium from one fibroblast cell line grown for 48 h to 80% confluency was transferred to the opposite cell line. After 4 h of incubation, the conditioned medium was removed, the cells were washed with buffer and then exposed to 7.5 MM arachidonic acid for 20 min, and the medium was assayed for PGE2 by RIA.
To determine if plasmalogen deficiency was responsible for the reduced PGE2 production by the peroxisomal-deficient fibroblasts, confluent monolayers were incubated with modified Eagle's MEM containing0. 1 MtM BSA supplemented with 5-12.5MgM 1-0-alkyl hexadecaglycerol (Sigma Chemical Co., St. Louis, MO) for 48 h. The medium was removed, and the cells were washed with buffer and then incubated for 20 min in 0.5 ml DPBS/0.1 MM BSA containing 7.5 MM arachidonic acid. The medium was removed and assayed for PGE2 by RIA. Modification ofcellular peroxide tone. To determine whether the oxyradical scavenger catalase had any effect on PGE2 formation, we incubated confluent cultures of normal or peroxisomal-deficient hu-1. Abbreviations used in this paper: DPBS, Dulbecco's PBS; H-7,
TBS, Tris-buffered saline. man skin fibroblasts with modified Eagle's MEM containing 0.1 uM BSA and 10-100 U/ml of catalase (46,500 U/mg protein, Sigma Chemical Co.) for 10 min to 2 h. After removal of the catalase-supplemented medium, the cells were washed with DPBS containing 0.1 M BSA and then incubated for 20 min in 0.5 ml of DPBS/0. 1 MM BSA supplemented with 7.5 MM arachidonic acid. The medium was removed and analyzed for PGE2 by RIA.
To increase the half-life and intracellular permeability of the added catalase, we also tested catalase conjugated to polyethylene glycol ( 16) . Normal and peroxisomal-deficient human fibroblasts were incubated in modified Eagle's MEM containing 1% heat-inactivated fetal bovine serum supplemented with 0. 125,0.25, and 0.5 mg/ml catalase-polyethylene glycol. After 24 h, the medium was removed, and the cells were washed and analyzed for PGE2 production by RIA.
To determine if H202 had any effect on fibroblast PGE2 production, confluent cultures of normal and peroxisomal-deficient human skin fibroblasts were incubated with modified Eagle's MEM containing 0.1 MuM BSA supplemented with 1-100 MM H202. After 10 min, the H202 containing medium was removed and the cells were washed and analyzed for PGE2 production by RIA.
Phorbol ester-stimulated PGE2 formation. To determine whether PMA (LC Services Corp., Woburn, MA) was capable of increasing PGE2 formation, we incubated monolayers of normal and Zellweger fibroblasts in Eagle's MEM containing 5% FBS supplemented with 10 nM PMA for 1-12 h. The PMA supplemented medium was removed and the cells were washed with buffer and then exposed to DPBS/0. 1 MM BSA containing 7.5 ,M arachidonic acid. After 20 min, the buffer solution was removed and the PGE2 content was measured by RIA.
To determine whether the increase in PGE2 formation after PMA was secondary to increased arachidonic acid release via enhanced phospholipase A2 activity, normal and Zellweger fibroblasts were labeled with [3Hjarachidonic acid (0.5 MCi/ml) for 12 h in Eagle's MEM containing 5% FBS. After the medium was removed and the cells were washed, aliquots of the medium were counted in a liquid scintillation spectrometer to determine the amount ofradioactivity taken up during the labelling period. Eagle's MEM containing 5% FBS supplemented with either 10 nM PMA or its vehicle was then added to the cultures for 12 h. At the appropriate time, 0.5 ml of medium containing the calcium ionophore A23 187 (final concentration 2 MM) was added to the cultures. After 20 min, the remaining medium was extracted with ethyl acetate and the extract was resuspended in acetonitrile. Aliquots were removed and counted in the liquid scintillation spectrometer to determine the amount of lipid-soluble radioactivity that was released.
To examine whether inhibitors of transcription or translation would interfere with the effect of PMA on PGE2 production, normal and Zellweger fibroblasts were incubated for 6 h in Eagle's MEM containing 5% FBS with or without 10 nM PMA. Additional incubations for 6 h contained PMA and either 1 Mg/ml cycloheximide or 2 Mg/ml actinomycin D (both from Sigma Chemical Co.). Cultures not exposed to PMA for 6 h but containing cyclohexamide or actinomycin D were also tested. After this medium was removed, the cells were incubated for 20 min with 7.5 MuM arachidonic acid, and the medium was analyzed for PGE2 by RIA.
To determine whether the effect of PMA on PGE2 production was mediated through protein kinase C, normal and Zellweger fibroblasts were incubated for 6 h with or without PMA as indicated above. Additional incubations for 6 h contained PMA and either 100 AM H-7 [1-(5-isoquinoline sulfonyl)-2-methyl piperazine dihydrochloride, Seikagaku America, St. Petersburg FL] or 10 mM staurosporine (Sigma Chemical Co.). Cultures not exposed to PMA but containing H-7 or staurosporine were also tested. The cells then were incubated with 7.5 MM arachidonic acid and the medium analyzed for PGE2 by RIA.
HPLC. The total radioactivity contained in a sample was determined initially by adding 4 ( 17) . Confluent cultures of normal, infantile Refsum's disease, and Zellweger human skin fibroblasts were grown in tissue culture flasks with 75 cm2 surface area, washed, scraped twice in 3 ml of cold PBS, and placed on ice. The cells were sedimented at 4VC at 3,000 g for 10 min. After the supernatant fluid was removed, the cell pellet was lysed in 1 ml of PBS containing 1% Triton X-100 (Surfact Amps; Pierce Chemical Co., Rockford, IL), 10 g/ml leupeptin, 1 mM phenylmethylsulfonylfluoride, 1 mM EDTA, and 1 mM diethyldithiocarbamic acid (all from Sigma Chemical Co.). The lysate was transferred to an Eppendorf tube and immersed in boiling water for 3 min, and then sedimented in a refrigerated microfuge at 27,000 g for 10 min. The supernatant solution was removed, placed in a Centricon-30 microconcentrator (Amicon Division, W. R. Grace and Co., Danvers, MA) and concentrated by centrifugation for 30-min intervals at 5,000 g and 4°C with 340 angle rotor. After the supernatant solution was concentrated to 100 Al, 20 Al was removed and assayed for protein content (18) . The remainder was kept at 4°C and assayed within 16 h.
Proteins in the concentrated cell lysates containing the solublized PGH synthase were separated through 12.5% SDS-PAGE according to the method of Laemmli ( 19) using the Mini Protean gel system (BioRad Laboratories, Richmond, CA). Sample aliquots equivalent to 100 jig of protein per lane were denatured by heating to 96°C for 4 Gels were stained with Coomassie Brilliant Blue to confirm that the transfer efficiency was > 90% and that all samples were transferred uniformly. Nitrocellulose membranes were saturated overnight at 4°C in Tris-buffered saline (TBS) containing 10% FBS and 2% BSA.
After saturation, the nitrocellulose membrane was washed in TBS/ 0.05% Tween and once in TBS for a total of 30 min. The membrane was incubated for 4 h at 25°C in 7.5 ml of TBS/2% BSA, pH 8.0, containing rabbit anti-PGH synthase antibody (Polyclonal rabbit anti-PGH synthase, Oxford Biomedical Research, Oxford, MI) diluted 1:100. The nitrocellulose membrane then was washed as before and incubated for 2 h at 25°C in 7.5 ml of TBS/2% BSA, pH 8.0, containing goat anti-Rabbit IgG conjugated with alkaline phosphatase (Sigma Chemical Co.) diluted 1 :10,000. After washing, the nitrocellulose was treated with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium (both from Sigma Chemical Co.) for color development and visualization. mRNA analysis. Total RNA was isolated from cell cultures under basal conditions and after treatment with PMA for 2-16 h by extraction with guanidium isothiocyanate and subsequent cesium chloride centrifugation according to the methods described by Chirgwin et al. (20) Analysis of the cellular fatty acid composition by gas chromatography indicated no difference in arachidonic acid content between normal (8.4% of total cell fatty acids) Zellweger (8.4%) and infantile Refsum's disease (8.1% ) fibroblasts. However, Table I demonstrates that the reduction in PGE2 formation also occurs in the Zellweger cells in response to A23 187, where the arachidonic acid is derived from intracellular stores. Prior supplementation with small amounts ofarachidonic acid failed to correct the decrease in A23 187-stimulated PGE2 production in the Zellweger cells.
To determine whether arachidonic acid was being shunted to other metabolic pathways, control and peroxisomal-deficient fibroblasts were incubated with 7.5 uM [1-14C]-arachidonic acid for 20 min and the radioactivity contained in the medium assayed by HPLC. Normal human skin fibroblasts converted 4.7% ofthe radioactivity to a single component with a HPLC retention time of 16.5 min, identical to that of standard PGE2 (Fig. 3, top) . Both Conditioned medium and alkyl glycerol supplementation. Another possibility is that the peroxisomal-deficient cells fail to produce a necessary activator, or produce an inhibitor of PG formation. To evaluate this, a crossover experiment was done with conditioned medium. After at least 48 h of growth, the conditioned medium from one fibroblast line was immediately Normal AA 300.
200.
100. PGE2 production, 10-100 ,M catalase was incubated with the Zellweger cells for 60-120 min, and the cells then were exposed to 7.5 ,uM arachidonic acid for 20 min. RIA analysis revealed that this pretreatment with catalase did not increase Zellweger fibroblast PGE2 production (data not shown). Because catalase was added to the medium, it may have had limited access to the intracellular space. Therefore, we attempted to more effectively increase the intracellular concentration of catalase by preincubating the cells for 24 h with 0.0 125, 0.25, and 0.5 mg/ml catalase conjugated to polyethylene glycol. Previous work by Beckman et al. (16) suggests that this is a more efficient way of increasing the 15- cellular catalase content and thereby lower intracellular H202 concentration. However, exposure to the catalase-polyethylene glycol preparation also did not increase PGE2 production when the Zellweger fibroblasts were subsequently incubated with 7.5 AtM arachidonic acid for 20 min (data not shown).
The alternative possibility is that because of aberrant catalase localization, the peroxide tone ofthe cell may be too low to trigger PG formation. If so, addition of H202 may overcome this deficiency. To test this, we incubated confluent monolayers of normal and Zellweger human skin fibroblasts with 1-100 ,iM H202 for 10 min, removed this medium, and then exposed the cells to 7.5 gM arachidonic for 20 min. Fig. 4 demonstrates that PGE2 formation in the Zellweger fibroblasts was not increased by prior treatment with H202. Furthermore, incubation of the normal fibroblasts with H202 resulted in a dose-dependent reduction in PGE2 formation. After exposure to 50 or 100 ,M H202, the amount of PGE2 produced by the normal cells was reduced to the level observed with the Zellweger cells.
Effect ofphorbol ester. PMA has been shown to increase PG synthesis in many cells by increasing PGH synthase formation (25-27) To determine ifthis would restore the defect in PGE2 production, monolayers of normal and Zellweger fibroblasts were incubated with 10 nM PMA for 1-12 h. After this medium was removed and the cells washed, they were incubated with DPBS/0.1 gM BSA supplemented with 7.5 ,uM arachidonic acid and the medium assayed by RIA. Fig. 5 demonstrates that after a 6-or 12-h incubation with PMA, PGE2 formation in the Zellweger fibroblasts was restored to a level identical to that seen in the normal human skin fibroblast treated in the same manner.
PMA's effect to increase PGE2 formation might be through its previously described effect of increasing phospholipase A2 activity and, hence, increasing the availability of arachidonic acid (28) . To determine whether this might be the mechanism of the PMA effect, monolayers of normal and Zellweger fibroblasts were labelled with [3H]arachidonic acid for 12 h. This medium was removed and the cells were incubated with 5% FBS supplemented with 10 nM PMA for an additional 12 h. A23187 at a final concentration of 2 ,uM was added to the cultures for 20 min, and the release of arachidonic acid was determined. Table II indicates that treatment with PMA in both the normal and Zellweger fibroblasts failed to augment the release of radioactivity from the pulse-labeled cells. Normal and Zellweger fibroblasts were grown to confluency and labeled with [3Hjarachidonic acid for 12 h. After removing the radiolabeled medium and counting aliquots to determine uptake, the fibroblasts were incubated in medium with or without 10 nM PMA for an additional 12 h, and 2 ,uM A23187 was then added to the cultures for 20 min. The medium was extracted with ethyl acetate, and aliquots were counted in a liquid scintillation spectrometer to determine the release ofradioactivity. This was calculated as the quotient of the counts released into the ethyl acetate extract of the medium, divided by the counts incorporated in the cells at the end of the pulse-labeling period. The data represent the mean±SEM ofthree separate determinations made with cultures studied on the same day.
To further investigate the mechanism through which PMA treatment increases PGE2 production in the peroxisomal deficient fibroblasts, we included either 1 Mig/ml cycloheximide or 2 Mg/ml actinomycin D with 10 nM PMA during the initial 6-h incubation. The cells then were exposed to 7.5 AM arachidonic acid for 20 min. Fig. 6 demonstrates that in the normal fibroblasts (top), treatment with PMA increased PGE2 production about twofold. Inclusion ofeither actinomycin D or cycloheximide eliminated the stimulatory effect of PMA (top, right), and these inhibitors also reduced arachidonic acid stimulated PGE2 production in the absence of PMA pretreatment (top, left). In the Zellweger fibroblasts (bottom), PMA also substantially increased PGE2 production. As was observed in the normal fibroblasts, inclusion ofeither cycloheximide or actinomycin D reduced basal PGE2 production and almost totally eliminated the PMA mediated increase.
To determine whether PMA produced this response by activating protein kinase C, we included 100 AM H-7 or 10 nM staurosporine with 10 nM PMA during an initial 6 h incubation and the cells then were exposed to 7.5 MM arachidonic acid for 20 min. Fig. 7 (29) .
PGH synthase mRNA. To determine whether a difference in PGH synthase mRNA could account for our PGE2 production findings, we carried out mRNA analysis in normal and Zellweger human skin fibroblasts. Fig. 9 is representative of three different Northern blots performed on RNA extracted from resting, unstimulated cultures. A single 4.2-kb band is visible in the normal skin fibroblasts (lane 1); this band is not present in the peroxisomal-deficient Zellweger fibroblasts. We also probed these Northern blots with ,B-actin cDNA and detected a band in both the normal and peroxisomal-deficient cell extracts. Thus, the absence of PGH synthase mRNA in the unstimulated Zellweger fibroblasts is not due to degradation of the mRNA in the sample.
The PGH synthase mRNA response ofnormal human skin fibroblasts between 2 and 16 h after PMA stimulation is shown in Fig. 10, lanes 1-4 . Two PGH synthase mRNA bands were detected. The 4.2-kb mRNA transcript, which had been detected in the quiescent cells (Fig. 9) , increased over time up to 8 h and then subsequently decreased. Densitometric analysis indicated that the maximum increase which occurred at 8 h was twofold. A smaller transcript which migrated with a 2.8-kb rRNA standard also was detected. This 2.8-kb mRNA ap- peared in parallel with the increased expression of the 4.2-kb mRNA transcript in the normal skin fibroblasts, and densitometric analysis indicated that it reached the same twofold maximum increase (Fig. 10, lanes 1-4) .
In peroxisomal-deficient Zellweger fibroblasts, the 4.2-kb mRNA transcript was detected at 2 h after PMA stimulation (Fig. 10, lanes 5-8) , and the maximum increase in the 4.2-kb mRNA transcript observed by densitometric tracing occurred between 6 and 8 h (Fig. 10, lanes 6 and 7) . However, the 2.8-kb mRNA transcript was not detected at any of these times after PMA stimulation in the peroxisomal-deficient cells.
Discussion
These results demonstrate that peroxisomal-deficient human skin fibroblasts have a marked decrease in both arachidonic acid and calcium ionophore-stimulated PG production. The substantial variability in the absolute values presented in Figs. 2, 4 , and 5 probably is due to differences in passage number and confluency, factors that could not be easily controlled because of the different properties of the various cell cultures. However, despite this quantitative variability, PGE2 production by peroxisomal-deficient human skin fibroblasts was al-PGH Syn Figure 8 . 29- confluency. The medium was removed, and the cells were scraped in ice-cold PBS and lysed in 3 ml of PBS containing 1% Triton X-100, 10 Mg/ml leupeptin, 1 mM EDTA, 1 mM diethyldithiocarbamic acid, and 1 mM phenylmethylsulfonylfluoride. The lysate was boiled and the supernatant concentrated to 100 Ml in Centricon-30 filters. 75 Mg of cell protein was loaded onto 12.5% SDS denaturing gels and electrophoresed for 2 h. The proteins were transferred to nitrocellulose. The nitrocellulose was then saturated at 40C in TBS supplemented with 10% FBS and 2% BSA. The next day, 7.5 ml of TBS/ 10% FBS/ 2% BSA containing a 1: 100 dilution of sheep anti-PGH synthase was added for 4 h. The primary antibody was removed and 7.5 ml of TBS/ 10% FBS/2% BSA, containing a 1:10,000 dilution of anti-rabbit IgG conjugated with alkaline phosphatase was added for an additional 2 h. The blots were stained with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium and developed for 15 min. Standard PGH synthase (lane 2) developed into a single band at 69 kD, and bands migrating nearly identical to this standard were detected in each of the human skin fibroblast lysates. Abbreviations: PGH Syn Std, PGH synthase standard; NL, normal human skin fibroblasts; Refsums, Refsum's disease fibroblasts; Zell, Zellweger disease fibroblasts.
ways reduced when compared with that of normal skin fibroblasts under the experimental conditions utilized.
Peroxisomes are the site ofPG catabolism through f-oxidation (30) , but this organelle is not considered to be involved in PG production. PGH synthase, the rate-limiting enzyme in PG synthesis ( 12) , is present in the endoplasmic reticulum and nuclear membrane (31 ) , and there is no indication that the other enzymes in the synthetic pathway are located in the peroxisomes. We also are unaware of any clinical reports of decreased PG production in peroxisomal deficiency diseases. Therefore, the observation that PG formation is reduced in peroxisomal-deficient cells is completely unexpected.
We initially explored whether the defect might involve arachidonic acid availability or metabolism. No decrease was observed, however, in the arachidonic acid content of the Zellweger cell lipids. This is consistent with our previous finding that the uptake and distribution ofradioactive arachidonic acid in Zellweger cells is the same as in normal human skin fibro-1 2 Figure 9 . PGH synthase mRNA analysis in unstimulated fibroblasts. blasts (8) . Furthermore, exposure of the Zellweger fibroblasts to elevated amounts of arachidonic acid failed to correct the deficiency, and HPLC analysis demonstrated that arachidonic acid is not being shunted into other eicosanoid products in the peroxisomal-deficient cells. The defect was also not overcome by the administration of O-alkylglycerol, which restores the ability of peroxisomal-deficient cells to synthesize plasmalogens (32) . However, the possibility that the deficient cells do not convert the O-alkylglycerol precursor to a specifically required plasmologen, such as the 1-vinyl ether 2-arachidonyl species, cannot be ruled out by these results.
Since the reduction in agonist stimulated PGE2 formation apparently is not related to arachidonic acid availability, it probably involves some aspect of the biosynthetic pathway. Western blots demonstrate that both the normal and mutant fibroblast lysates contain a 72-74-kD doublet that cross-reacts with an antibody to PGH synthase. This is consistent with the reported PGH synthase subunit molecular mass of about 72 kD (33) . The presence ofa doublet rather than a single component in the Western blots also was noted in the normal fibroblasts, and it has been reported in transformed 3T3 cells (29) .
The results in Fig. 10 (34) . The growth medium used for these studies contained 20% FBS. Apparently, this provided enough mitogenic activity to maintain the presence ofsome 4.2-kb PGH synthase mRNA in the unstimulated fibroblasts. In this regard, a 4.8-kb PGH synthase mRNA transcript has been detected in unstimulated normal human monocytes (35) , and a 5.5-kb transcript is present in unstimulated normal human lung fibroblasts (36) . In these cells, however, a 2.7-2.8-kb PGH synthase mRNA transcript also was detected (35, 36) . Why the smaller mRNA transcript, which probably encodes the constitutive PGH synthaseor Cox-1 (34), was detected in the normal human skin fibroblasts only after exposure to PMA cannot be explained.
No PGH synthase mRNA was detected by Northern blot analysis in the unstimulated Zellweger fibroblasts even though the ,3-actin probe demonstrated that substantial quantities of mRNA were added to the gels (Fig. 9) . Since these cells produce a small amount of PGE2 and contain PGH synthase protein as determined by Western blotting (Fig. 8) , PGH synthase mRNA transcripts must occur at some stage in the Zellweger cells. Either the unstimulated Zellweger cells were assayed at a stage when these transcripts are no longer retained, or the Northern analysis is too insensitive to detect the low levels that are present. The latter explanation seems more likely because Northern blot analysis is known to have low sensitivity in detecting transcripts for eicQsanoid-producing enzymes in certain cells, e.g., 12-lipoxygenase mRNA expression in human erythroleukemia cells (37) .
It is known that PGH synthase can be induced by treatment of cell cultures with phorbol esters (27, (38) (39) (40) . This prompted us to investigate whether exposure of the peroxisomal-deficient human skin fibroblasts to PMA might overcome the deficit in PGE2 production. A time-dependent increase in PGE2 formation was observed (Fig. 5) , and this was associated with the appearance of the 4.2-kb PGH synthase mRNA transcript (Fig. 10, lanes 5-8) . No clearly visible, distinct 2.8-kb transcript was detected in the Zellweger cells at any time after PMA exposure. When the normal fibroblasts were treated with PMA, the abundance of 4.2-kb transcript, which was present in these cells in the unstimulated state, also increased. In addition, a 2.8-kb transcript appeared in the normal cell extracts and increased in parallel with the larger transcript (Fig. 10, lanes  1-4) . This suggests that in the normal human fibroblasts, the 2.8-kb PGH synthase mRNA may be derived from the 4.2-kb transcript. In this regard, a parallel increase in the expression of spliced and unspliced PGH synthase transcripts has been observed when human lung fibroblasts are treated with PMA and serum (36) . Alternatively, the 2.8-kb transcript may represent the inducible form of PGH synthase that was observed previously when human endothelial cells were exposed to interleukin 1 (41 ) . The failure to observe any PMA-induced increase in total arachidonic acid release from either the normal or Zellweger fibroblast (Table II) , an indirect measure of phospholipase A2 activity, is consistent with the effect of PMA occurring at the level of PGH synthase in both cases.
After exposure to PMA, there was a 4-h delay before PGE2 production reached maximum levels in the normal fibroblasts and a 6-h delay in the Zellweger cells (Fig. 5) . Such a lag period also is compatible with a mechanism involving PGH synthase gene expression. Likewise, the inhibitory effects of actinomycin D and cycloheximide suggest that gene expression is involved. Results obtained in 3T3 fibroblasts exposed to platelet derived growth factor are consistent with this interpretation; the increase in PGE2 synthesis resulting from production of PGH synthase exhibited a lag period of 2-6 hand was inhibited by cycloheximide and actinomycin D (42) . Since PMA activates protein kinase C, this enzyme probably mediates the response in the human skin fibroblasts, as it does in other cell lines (12) . This is supported by the fact that staurosporine and H-7 inhibited the increase in PGE2 production resulting from exposure to PMA.
The alternative possibility that the activity of the PGH synthase is reduced in peroxisomal-deficient cells appears to be excluded by the present results. One factor that regulates PGH synthase activity is the intracellular peroxide tone (43) . Peroxi-somes generate H202 through fatty acid /-oxidation (3, 44) and they contain catalase, the enzyme that breaks down H202 ( 1, 2) . Depending on which of these processes predominates, a peroxisomal deficiency might either increase or decrease the peroxide tone. However, addition of neither H202 nor a polyethylene glycol-catalase complex stimulated PGE2 output by the Zellweger cultures. The concentrations of H202 tested apparently were effective because, as in endothelial cells (45) , prostaglandin production was reduced when the normal fibroblasts were treated with these quantities ofH202 (Fig. 4) . Based on these findings, it seems unlikely that abnormalities in peroxide tone are responsible for the decreased PGE2 formation in the peroxisomal deficient cells.
As opposed to the present findings, Tiffany et al. (46) have observed that PGE2 production is increased in peroxisomal deficient fibroblasts. The culture conditions, however, were quite different in the two studies. Tiffany et al. (46) utilized a gas phase containing 10% C02 and supplemented the growth media with 10% FBS, whereas we used 5% CO2 and 20% FBS. In addition, Tiffany et al. (46) tested the fibroblasts after exposure to a serum-free medium supplemented with 2% TCM, a proprietary mixture containing vitamins, growth factors, and fatty acids. Some or all ofthese factors might have modified the response in the mutant cells, leading to an increase rather than the decrease in PGE2 formation that we observed.
In conclusion, our findings demonstrate that under commonly used culture conditions, the capacity ofperoxisomal-deficient human skin fibroblasts to produce PGs is impaired. Therefore, peroxisome integrity appears to be necessary for normal PG formation, a relationship not previously recognized in eukaryotic cells. These results also suggest the possibility that some of the abnormalities associated with peroxisomal deficiency syndromes may be related to an inability to produce adequate amounts of PGs.
